--- title: Buy Evista (Raloxifene) 60mg Pills Online description: Evista (Raloxifene) 60mg pills prevent osteoporosis in postmenopausal women. Get securely from our online pharmacy with verified quality. type: product language: en url: https://ayudadiabetes.com/order-evista-online-en availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 24.99 price_max: 431.99 currency: USD offers: - name: 60mg x 10 pills price: 24.99 - name: 60mg x 30 pills price: 64.99 - name: 60mg x 60 pills price: 125.99 - name: 60mg x 90 pills price: 180.99 - name: 60mg x 120 pills price: 229.99 - name: 60mg x 180 pills price: 328.99 - name: 60mg x 360 pills price: 431.99 --- # Buy Evista (Raloxifene) 60mg Pills Online Evista, containing raloxifene, is a selective estrogen receptor modulator developed by Eli Lilly. It reduces osteoporosis risk and invasive breast cancer in postmenopausal women. Supports bone health without uterine stimulation. Order Evista in 60mg pill form from our reliable online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **60mg** | 10 pills | **$24.99** | $2.47 | In Stock | | **60mg** | 30 pills | **$64.99** | $2.15 | In Stock | | **60mg** | 60 pills | **$125.99** | $2.10 | In Stock | | **60mg** | 90 pills | **$180.99** | $2.01 | In Stock | | **60mg** | 120 pills | **$229.99** | $1.92 | In Stock | | **60mg** | 180 pills | **$328.99** | $1.83 | In Stock | | **60mg** | 360 pills | **$431.99** | $1.20 | In Stock | [Buy Now](https://ayudadiabetes.com/order-evista-online-en) ## Introduction Evista contains the active compound raloxifene and is supplied as a 60 mg oral pill. It belongs to the class of selective estrogen receptor modulators (SERMs) and is primarily used to prevent and treat osteoporosis in post-menopausal women. In addition, raloxifene reduces the risk of invasive breast cancer in certain women at high risk. ## Quick Reference Facts **Active Ingredient** : Raloxifene **Form** : Pill 60 mg **Primary and Off-Label Uses** : Osteoporosis (post-menopausal women) : Prevention of breast cancer (high-risk post-menopausal women) : Treatment of osteoporosis (men) ## What is Evista? Evista is a medication whose sole active ingredient is raloxifene. It is classified as a selective estrogen receptor modulator, a drug class that binds to estrogen receptors and produces tissue-specific agonist or antagonist effects. Although the brand name Evista is well known, this article discusses the generic version of medications containing raloxifene. Generic alternatives are marketed under brand names such as Evista and are bioequivalent, offering comparable efficacy and safety at a lower cost. ## How Evista Works Raloxifene binds to estrogen receptors in bone and breast tissue. In bone, it mimics estrogen, leading to decreased bone resorption and modestly increased bone formation, which strengthens skeletal material and reduces fracture risk. In breast and uterine tissue, raloxifene acts as an antagonist, preventing estrogen-driven cell proliferation and thereby lowering the incidence of estrogen-dependent cancers. The drug is well absorbed after oral administration, reaches peak plasma levels within 4-6 hours, and is metabolised mainly by hepatic glucuronidation before excretion in the feces. Its half-life is approximately 27 hours, supporting once-daily dosing. ## Conditions Treated with Evista - **Post-menopausal osteoporosis** - Raloxifene increases bone mineral density, especially in the lumbar spine and hip, thereby reducing vertebral fracture risk. - **Prevention of invasive breast cancer** - In women with osteoporosis who are also at elevated breast-cancer risk, raloxifene lowers the likelihood of developing estrogen-receptor-positive tumours. - **Male osteoporosis** - Although less common, raloxifene can be used off-label for men with osteoporosis when other therapies are unsuitable, offering bone-protective benefits. ## Is Evista the Right Medication for You? Evista is most appropriate for post-menopausal women diagnosed with osteoporosis or those at high risk for estrogen-dependent breast cancer who also have low-to-moderate cardiovascular risk. It is especially useful when a patient wants a non-hormonal option for bone health. Contra-indications include a history of venous thromboembolism, active liver disease, and known hypersensitivity to raloxifene. Women who are pregnant, breastfeeding, or have unexplained vaginal bleeding should avoid the drug. Clinicians may favour Evista over estrogen therapy when the risk-benefit profile favours bone protection without stimulating uterine tissue. ## Buying Evista from [our online pharmacy](https://ayudadiabetes.com/order-evista-online-en) ### Why Choose Our Service? Access to raloxifene can be costly through conventional pharmacies, especially when brand-name options dominate the market. [our online pharmacy](https://ayudadiabetes.com/order-evista-online-en) provides a discreet, convenient route to obtain the generic 60 mg pill at prices close to the manufacturer’s cost. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of generic raloxifene is verified for compliance with recognised regulatory standards before shipment. ### Pricing & Access Our pharmacy service offers the generic version of raloxifene at a fraction of the price of brand-name Evista. This makes long-term osteoporosis management more affordable, particularly for patients with limited insurance coverage. ### Discreet Delivery Orders are packaged in neutral, unbranded envelopes and dispatched via express delivery, typically arriving within 7 days, or by standard airmail in approximately 3 weeks. Your privacy and convenience are paramount. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing:** One 60 mg tablet taken orally once daily, with or without food. - **Missed dose:** If a dose is forgotten, take it as soon as remembered unless it is near the time of the next scheduled dose; in that case, skip the missed tablet and continue with the regular regimen. Do not double-dose. - **Suspected overdose:** Contact emergency services or a poison-information centre immediately. Over-dose symptoms may include nausea, vomiting, or severe dizziness. - **Administration notes:** Avoid taking raloxifene with large amounts of calcium supplements at the same time, as calcium can reduce absorption. Alcohol does not have a direct interaction but excessive intake may increase the risk of thrombotic events. Do not operate heavy machinery if you feel dizzy or light-headed after dosing. ## Safety Information ### ⚠️ Who Should Not Take Evista - History of deep-vein thrombosis, pulmonary embolism, or other thrombo-embolic disorders. - Known hypersensitivity to raloxifene or any tablet excipients. - Active or past estrogen-dependent malignancies (e.g., breast cancer). - Severe hepatic impairment. ### Common Side Effects - Hot flashes (up to 30 % of users) - usually transient and manageable. - Leg cramps or muscle pain - may be reduced by gentle stretching. - Mild nausea or stomach upset - can be taken with food to minimise. ### Serious Side Effects (Seek Immediate Medical Help) - Swelling, pain, or redness in the leg suggestive of deep-vein thrombosis. - Sudden shortness of breath, chest pain, or coughing up blood - possible pulmonary embolism. - Stroke symptoms such as facial drooping, arm weakness, or speech difficulty. ### Drug & Food Interactions - **Warfarin:** Raloxifene may increase anticoagulant effect; monitor INR closely. - **CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin):** May raise raloxifene plasma levels; dose adjustment may be required. - **Calcium carbonate supplements:** Should be taken at least 2 hours apart to avoid reduced absorption. ## Off-Label and Investigational Uses of Evista - **Male osteoporosis:** Small clinical studies have examined raloxifene for bone preservation in men, showing modest increases in bone density, though this use remains off-label. - **Prevention of coronary artery disease:** Early investigations suggested potential cardiovascular benefits, but larger trials did not confirm a protective effect, and the indication is not approved. - **Management of estrogen-related dermatologic conditions:** Limited case reports describe improvement in certain skin conditions, but evidence is insufficient for routine use. ## Storage & Handling - Store tablets in a dry place at temperatures between 15 °C and 30 °C (59 °F - 86 °F). - Keep the container tightly closed and protect from excess moisture and direct sunlight. - Do not use tablets after the expiry date printed on the pack. - Dispose of any unused medication by returning it to a pharmacy or following local hazardous-waste guidelines. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Evista tablets?** Yes, you may carry a personal supply for up to three months, but keep them in their original packaging and bring a copy of the prescription or a doctor’s note if requested at customs. - **Should I avoid any particular foods while taking Evista?** Calcium-rich foods or supplements should be spaced at least two hours apart from the dose to ensure optimal absorption of raloxifene. **Product Information** - **What does an Evista tablet look like?** The generic 60 mg tablet is typically round, white to off-white, and may be film-coated; exact appearance can vary between manufacturers. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with lactose intolerance should verify the formulation with the supplier. **Regulatory & Safety Nuances** - **Will Evista show up on a standard drug test?** Raloxifene is not screened for in routine workplace drug testing panels, as it is not a controlled substance. - **Is Evista safe for athletes subject to anti-doping regulations?** Raloxifene is not listed on the World Anti-Doping Agency prohibited list, but athletes should check with their governing body for any sport-specific rules. **Scientific & Clinical Curiosity** - **How does raloxifene differ from traditional hormone replacement therapy?** Unlike estrogen therapy, raloxifene acts as an estrogen antagonist in breast and uterine tissue while mimicking estrogen in bone, reducing the risk of hormone-dependent cancers. - **What major clinical trial established Evista’s efficacy for breast-cancer risk reduction?** The Multiple Outcomes of Raloxifene Evaluation (MORE) trial demonstrated a statistically significant reduction in invasive breast cancer incidence among post-menopausal women with osteoporosis. ## Glossary **Selective Estrogen Receptor Modulator (SERM)** : A class of compounds that selectively stimulate or block estrogen receptors in different tissues, providing targeted therapeutic effects. **Bone Mineral Density (BMD)** : A measurement of the amount of mineral (mostly calcium) contained in a certain volume of bone, used to assess osteoporosis risk. **Venous Thromboembolism (VTE)** : A condition in which blood clots form in the veins, encompassing deep-vein thrombosis and pulmonary embolism. ## Disclaimer The information provided about **Evista** is intended for general educational purposes and does not substitute professional medical consultation. All therapeutic decisions, including those concerning off-label applications, should be made under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://ayudadiabetes.com/order-evista-online-en) supplies generic raloxifene for individuals who may encounter limited availability through conventional channels or who seek cost-effective alternatives. Always discuss any medication changes with your doctor before initiating, altering, or discontinuing treatment.